WallStreetZenWallStreetZen

NASDAQ: HOWL
Werewolf Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for HOWL

Based on 1 analyst offering 12 month price targets for Werewolf Therapeutics Inc.
Min Forecast
$15.00+131.48%
Avg Forecast
$15.00+131.48%
Max Forecast
$15.00+131.48%

Should I buy or sell HOWL stock?

Based on 1 analyst offering ratings for Werewolf Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HOWL stock forecasts and price targets.

HOWL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-07

1 of 1

Forecast return on equity

Is HOWL forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is HOWL forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

HOWL revenue forecast

What is HOWL's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$23.5M+17.84%
Avg 2 year Forecast
$25.5M+27.86%
Avg 3 year Forecast
$50.0M+150.71%
HOWL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HOWL revenue growth forecast

How is HOWL forecast to perform vs Biotechnology companies and vs the US market?
Company
29.76%
Industry
39.22%
Market
10.52%
HOWL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HOWL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HOWL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HOWL$6.48$15.00+131.48%Buy
IMMP$2.33N/AN/A
KOD$5.26$2.50-52.47%Sell
LCTX$1.48$6.50+339.19%Strong Buy
QSI$1.97$4.00+103.05%Buy

Werewolf Therapeutics Stock Forecast FAQ

Is Werewolf Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HOWL) stock is to Buy HOWL stock.

Out of 1 analyst, 0 (0%) are recommending HOWL as a Strong Buy, 1 (100%) are recommending HOWL as a Buy, 0 (0%) are recommending HOWL as a Hold, 0 (0%) are recommending HOWL as a Sell, and 0 (0%) are recommending HOWL as a Strong Sell.

If you're new to stock investing, here's how to buy Werewolf Therapeutics stock.

What is HOWL's revenue growth forecast for 2024-2026?

(NASDAQ: HOWL) Werewolf Therapeutics's forecast annual revenue growth rate of 29.76% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Werewolf Therapeutics's revenue in 2024 is $19,943,000.On average, 2 Wall Street analysts forecast HOWL's revenue for 2024 to be $1,004,323,989, with the lowest HOWL revenue forecast at $854,743,820, and the highest HOWL revenue forecast at $1,153,904,157. On average, 2 Wall Street analysts forecast HOWL's revenue for 2025 to be $1,089,798,371, with the lowest HOWL revenue forecast at $42,737,191, and the highest HOWL revenue forecast at $2,136,859,550.

In 2026, HOWL is forecast to generate $2,136,859,550 in revenue, with the lowest revenue forecast at $2,136,859,550 and the highest revenue forecast at $2,136,859,550.

What is HOWL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: HOWL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is HOWL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HOWL price target, the average HOWL price target is $15.00, with the highest HOWL stock price forecast at $15.00 and the lowest HOWL stock price forecast at $15.00.

The Wall Street analyst predicted that Werewolf Therapeutics's share price could reach $15.00 by Mar 7, 2025. The average Werewolf Therapeutics stock price prediction forecasts a potential upside of 131.48% from the current HOWL share price of $6.48.

What is HOWL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: HOWL) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.